BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Hydralazine

A direct-acting vasodilator that is used as an antihypertensive agent.

297+ PubMed studies analyzed · 19 RCTs · Evidence Score: 44.8

Research Domains

Hydralazine has been studied across 13 research domains including ❤️ Cardiovascular, 🫁 Liver & Detox, 🫘 Kidney, 🧠 Focus & Attention, 🦴 Bone & Joint. The primary research focus is ❤️ Cardiovascular with 48% of studies addressing this area.

Loading evidence profile...

This evidence profile for Hydralazine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.